Standpoint Research Starts Gilead Sciences (GILD) at Buy
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $147.87 +0.13%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 41
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 41
Join SI Premium – FREE
Standpoint Research initiated coverage on Gilead Sciences (NASDAQ: GILD) with a Buy rating and a price target of $110.00.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $82.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Nokia (NOK) at Buy, 'attractive valuation entry point'
- Morgan Stanley Assumes Telefonica S.A. (TEF:SM) (TEF) at Equalweight
- A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
Create E-mail Alert Related Categories
New CoverageRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
